TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Thor Life Science Consulting AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
2,162 |
| Financial expenses |
11
|
21
|
0 |
| Earnings before taxes |
101
|
-13
|
1,426 |
| EBITDA |
-25
|
-30
|
1,424 |
| Total assets |
2,053
|
2,227
|
2,518 |
| Current assets |
2,053
|
2,227
|
2,493 |
| Current liabilities |
-9
|
242
|
516 |
| Equity capital |
2,032
|
1,955
|
1,969 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
99.0%
|
87.8%
|
78.2% |
| Turnover per employee |
0
|
0
|
2,162 |
| Profit as a percentage of turnover | 66.0% | ||
| Return on assets (ROA) |
5.5%
|
0.4%
|
56.6% |
| Current ratio |
-22811.1%
|
920.2%
|
483.1% |
| Return on equity (ROE) |
5.0%
|
-0.7%
|
72.4% |
| Change turnover |
0
|
-2,162
|
773 |
| Change turnover % |
-100%
|
56% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.